Bulk Manufacturer of Controlled Substances Application: Bulk Manufacturer of Marihuana: JW Colorado, LLC, 9538-9539 [2021-02972]

Download as PDF 9538 Federal Register / Vol. 86, No. 29 / Tuesday, February 16, 2021 / Notices of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before March 18, 2021. Such persons may also file a written request for a hearing on the application on or before March 18, 2021. Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette ADDRESSES: Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this is notice that on January 15, 2021, Sigma Aldrich Co., LLC, 3500 Dekalb Street, Saint Louis, Missouri 63118– 4103, applied to be registered as an importer of the following basic class(es) of controlled substance(s): Controlled substance Drug code khammond on DSKJM1Z7X2PROD with NOTICES Cathinone ........................................................................................................................................................................ Methcathinone ................................................................................................................................................................. Mephedrone (4-Methyl-N-methylcathinone) .................................................................................................................... Gamma Hydroxybutyric Acid ........................................................................................................................................... Tetrahydrocannabinols .................................................................................................................................................... 4-Bromo-2,5-dimethoxyamphetamine ............................................................................................................................. 4-Bromo-2,5-dimethoxyphenethylamine .......................................................................................................................... 2,5-Dimethoxyamphetamine ............................................................................................................................................ 3,4-Methylenedioxyamphetamine .................................................................................................................................... 3,4-Methylenedioxy-N-ethylamphetamine ....................................................................................................................... 3,4-Methylenedioxymethamphetamine ............................................................................................................................ 4-Methoxyamphetamine .................................................................................................................................................. Dimethyltryptamine .......................................................................................................................................................... N-Benzylpiperazine .......................................................................................................................................................... Heroin .............................................................................................................................................................................. Normorphine .................................................................................................................................................................... Amobarbital ...................................................................................................................................................................... Secobarbital ..................................................................................................................................................................... Nabilone ........................................................................................................................................................................... Phencyclidine ................................................................................................................................................................... Ecgonine .......................................................................................................................................................................... Ethylmorphine .................................................................................................................................................................. Levorphanol ..................................................................................................................................................................... Meperidine ....................................................................................................................................................................... Thebaine .......................................................................................................................................................................... Opium, powdered ............................................................................................................................................................ Levo-alphacetylmethadol ................................................................................................................................................. The company plans to import the listed controlled substances for sale to research facilities for drug testing and analysis. In reference to drug code 7370 (Tetrahydrocannabinols) the company plans to import synthetic Tetrahydrocannabinols. No other activity for this drug code is authorized for this registration. Approval of permit applications will occur only when the registrant’s business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of Food and Drug Administration-approved or nonapproved finished dosage forms for commercial sale. William T. McDermott, Assistant Administrator. [FR Doc. 2021–02978 Filed 2–12–21; 8:45 am] BILLING CODE P VerDate Sep<11>2014 17:04 Feb 12, 2021 Jkt 253001 Drug Enforcement Administration [Docket No. DEA–775] Bulk Manufacturer of Controlled Substances Application: Bulk Manufacturer of Marihuana: JW Colorado, LLC Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: The Drug Enforcement Administration (DEA) is providing notice of an application it has received from an entity applying to be registered to manufacture in bulk basic class(es) of controlled substances listed in schedule I. DEA intends to evaluate this and other pending applications according to its regulations governing the program of growing marihuana for scientific and medical research under DEA registration. SUMMARY: PO 00000 Frm 00062 Fmt 4703 Sfmt 4703 I I I I I I I I I I I I I I I I II II II II II II II II II II II Registered bulk manufacturers of the affected basic class(es), and applicants therefor, may file written comments on or objections to the issuance of the proposed registration on or before April 19, 2021. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. To ensure proper handling of comments, please reference Docket No. DEA–775 in all correspondence, including attachments. SUPPLEMENTARY INFORMATION: The Controlled Substances Act (CSA) prohibits the cultivation and distribution of marihuana except by persons who are registered under the CSA to do so for lawful purposes. In accordance with the purposes specified in 21 CFR 1301.33(a), DEA is providing notice that the entity identified below has applied for registration as a bulk DATES: DEPARTMENT OF JUSTICE 1235 1237 1248 2010 7370 7391 7392 7396 7400 7404 7405 7411 7435 7493 9200 9313 2125 2315 7379 7471 9180 9190 9220 9230 9333 9639 9648 Schedule E:\FR\FM\16FEN1.SGM 16FEN1 9539 Federal Register / Vol. 86, No. 29 / Tuesday, February 16, 2021 / Notices manufacturer of schedule I controlled substances. In response, registered bulk manufacturers of the affected basic class(es), and applicants therefor, may file written comments on or objections of the requested registration, as provided in this notice. This notice does not constitute any evaluation or determination of the merits of the application submitted. The applicant plans to manufacture bulk active pharmaceutical ingredients (APIs) for product development and distribution to DEA-registered researchers. If the application for registration is granted, the registrant would not be authorized to conduct other activity under this registration aside from those coincident activities specifically authorized by DEA regulations. DEA will evaluate the application for registration as a bulk manufacturer for compliance with all applicable laws, treaties, and regulations and to ensure adequate safeguards against diversion are in place. As this applicant has applied to become registered as a bulk manufacturer of marihuana, the application will be evaluated under the criteria of 21 U.S.C. 823(a). DEA will conduct this evaluation in the manner described in the rule published at 85 FR 82333 on December 18, 2020, and reflected in DEA regulations at 21 CFR part 1318. In accordance with 21 CFR 1301.33(a), DEA is providing notice that on January 13, 2021, JW Colorado, LLC, 3601 Freedom Road, Trinidad, Colorado 81082, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substances: Controlled substance Marihuana Extract ........ Marihuana ..................... Drug code Schedule 7350 7360 I I William T. McDermott, Assistant Administrator. [FR Doc. 2021–02972 Filed 2–12–21; 8:45 am] BILLING CODE P DEPARTMENT OF JUSTICE khammond on DSKJM1Z7X2PROD with NOTICES Drug Enforcement Administration [Docket No. DEA–779] Bulk Manufacturer of Controlled Substances Application: Bulk Manufacturer of Marihuana: Titan Health LLC Drug Enforcement Administration, Justice. AGENCY: VerDate Sep<11>2014 17:04 Feb 12, 2021 Jkt 253001 ACTION: Notice of application. The Drug Enforcement Administration (DEA) is providing notice of an application it has received from an entity applying to be registered to manufacture in bulk basic class(es) of controlled substances listed in schedule I. DEA intends to evaluate this and other pending applications according to its regulations governing the program of growing marihuana for scientific and medical research under DEA registration. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefor, may file written comments on or objections to the issuance of the proposed registration on or before April 19, 2021. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW 8701 Morrissette Drive, Springfield, Virginia 22152. To ensure proper handling of comments, please reference Docket No. DEA–779 in all correspondence, including attachments. SUPPLEMENTARY INFORMATION: The Controlled Substances Act (CSA) prohibits the cultivation and distribution of marihuana except by persons who are registered under the CSA to do so for lawful purposes. In accordance with the purposes specified in 21 CFR 1301.33(a), DEA is providing notice that the entity identified below has applied for registration as a bulk manufacturer of schedule I controlled substances. In response, registered bulk manufacturers of the affected basic class(es), and applicants therefor, may file written comments on or objections of the requested registration, as provided in this notice. This notice does not constitute any evaluation or determination of the merits of the application submitted. The applicant plans to manufacture bulk active pharmaceutical ingredients (APIs) for product development and distribution to DEA registered researchers. If the application for registration is granted, the registrant would not be authorized to conduct other activity under this registration aside from those coincident activities specifically authorized by DEA regulations. DEA will evaluate the application for registration as a bulk manufacturer for compliance with all applicable laws, treaties, and regulations and to ensure adequate safeguards against diversion are in place. As this applicant has applied to become registered as a bulk SUMMARY: PO 00000 Frm 00063 Fmt 4703 Sfmt 4703 manufacturer of marihuana, the application will be evaluated under the criteria of 21 U.S.C. 823(a). DEA will conduct this evaluation in the manner described in the rule published at 85 FR 82333 on December 18, 2020, and reflected in DEA regulations at 21 CFR part 1318. In accordance with 21 CFR 1301.33(a), DEA is providing notice that on January 18, 2021, Titan Health LLC, 5959 East 39th Avenue, Suite 102, Denver, Colorado 80207 applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substances: Controlled substance Marihuana Extract ........ Marihuana ..................... Drug code 7350 7360 Schedule I I William T. McDermott, Assistant Administrator. [FR Doc. 2021–02968 Filed 2–12–21; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–776] Bulk Manufacturer of Controlled Substances Application: PCI Synthesis Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: PCI Synthesis, has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before April 19, 2021. Such persons may also file a written request for a hearing on the application on or before April 19, 2021. ADDRESS: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUMMARY: In accordance with 21 CFR 1301.33(a), this is notice that on March 24, 2020, PCI Synthesis, 9 Opportunity Way, Newburyport, Massachusetts 01950– 0195, applied to be registered as a bulk SUPPLEMENTARY INFORMATION: E:\FR\FM\16FEN1.SGM 16FEN1

Agencies

[Federal Register Volume 86, Number 29 (Tuesday, February 16, 2021)]
[Notices]
[Pages 9538-9539]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-02972]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-775]


Bulk Manufacturer of Controlled Substances Application: Bulk 
Manufacturer of Marihuana: JW Colorado, LLC

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: The Drug Enforcement Administration (DEA) is providing notice 
of an application it has received from an entity applying to be 
registered to manufacture in bulk basic class(es) of controlled 
substances listed in schedule I. DEA intends to evaluate this and other 
pending applications according to its regulations governing the program 
of growing marihuana for scientific and medical research under DEA 
registration.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefor, may file written comments on or objections to 
the issuance of the proposed registration on or before April 19, 2021.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152. To ensure proper 
handling of comments, please reference Docket No. DEA-775 in all 
correspondence, including attachments.

SUPPLEMENTARY INFORMATION: The Controlled Substances Act (CSA) 
prohibits the cultivation and distribution of marihuana except by 
persons who are registered under the CSA to do so for lawful purposes. 
In accordance with the purposes specified in 21 CFR 1301.33(a), DEA is 
providing notice that the entity identified below has applied for 
registration as a bulk

[[Page 9539]]

manufacturer of schedule I controlled substances. In response, 
registered bulk manufacturers of the affected basic class(es), and 
applicants therefor, may file written comments on or objections of the 
requested registration, as provided in this notice. This notice does 
not constitute any evaluation or determination of the merits of the 
application submitted.
    The applicant plans to manufacture bulk active pharmaceutical 
ingredients (APIs) for product development and distribution to DEA-
registered researchers. If the application for registration is granted, 
the registrant would not be authorized to conduct other activity under 
this registration aside from those coincident activities specifically 
authorized by DEA regulations. DEA will evaluate the application for 
registration as a bulk manufacturer for compliance with all applicable 
laws, treaties, and regulations and to ensure adequate safeguards 
against diversion are in place.
    As this applicant has applied to become registered as a bulk 
manufacturer of marihuana, the application will be evaluated under the 
criteria of 21 U.S.C. 823(a). DEA will conduct this evaluation in the 
manner described in the rule published at 85 FR 82333 on December 18, 
2020, and reflected in DEA regulations at 21 CFR part 1318.
    In accordance with 21 CFR 1301.33(a), DEA is providing notice that 
on January 13, 2021, JW Colorado, LLC, 3601 Freedom Road, Trinidad, 
Colorado 81082, applied to be registered as a bulk manufacturer of the 
following basic class(es) of controlled substances:

------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
Marihuana Extract......................     7350  I
Marihuana..............................     7360  I
------------------------------------------------------------------------


William T. McDermott,
Assistant Administrator.
[FR Doc. 2021-02972 Filed 2-12-21; 8:45 am]
BILLING CODE P